Salivary α-synuclein and DJ-1: Potential Biomarkers for Parkinson's Disease

Overview

Journal Brain

Publisher Oxford University Press

Specialty Neurology

Date 2011 Feb 26

PMID 21349902

Citations 109

Authors

Ivana Devic

HyeJin Hwang

John Scott Edgar

Kenneth Izutsu

Richard Presland

Catherine Pan

David R Goodlett

Yu Wang

Jeff Armaly

Vitor Tumas

Cyrus P Zabetian

James B Leverenz

Min Shi

Jing Zhang

Affiliations

Soon will be listed here.

Citing Articles

Dysregulation of a Heme Oxygenase-Synuclein Axis in Parkinson Disease.

Cressatti M, Schipper H NeuroSci. 2024; 3(2):284-299.

PMID: 39483365 PMC: 11523740. DOI: 10.3390/neurosci3020020.

Single-molecule characterization of salivary protein aggregates from Parkinson's disease patients: a pilot study.

Furlepa M, Zhang Y, Lobanova E, Kahanawita L, Vivacqua G, Williams-Gray C Brain Commun. 2024; 6(3):fcae178.

PMID: 38863577 PMC: 11166177. DOI: 10.1093/braincomms/fcae178.

A systematic review of salivary biomarkers in Parkinson's disease.

De Bartolo M, Belvisi D, Mancinelli R, Costanzo M, Caturano C, Leodori G Neural Regen Res. 2024; 19(12):2613-2625.

PMID: 38595280 PMC: 11168506. DOI: 10.4103/NRR.NRR-D-23-01677.

Alpha-synuclein in peripheral body fluid as a biomarker for Parkinson's disease.

Shu H, Zhang P, Gu L Acta Neurol Belg. 2024; 124(3):831-842.

PMID: 38170418 DOI: 10.1007/s13760-023-02452-2.

Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.

Chhabra P, Rishabh , Singla S, Choudhary S, Kohli S, Bansal N CNS Neurol Disord Drug Targets. 2023; 23(8):996-1014.

PMID: 37815179 DOI: 10.2174/0118715273258646230920074421.

References

Probst A, Bloch A, Tolnay M . New insights into the pathology of Parkinson's disease: does the peripheral autonomic system become central?. Eur J Neurol. 2008; 15 Suppl 1:1-4. DOI: 10.1111/j.1468-1331.2008.02057.x. View

Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H . Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology. 1999; 52(6):1269-71. DOI: 10.1212/wnl.52.6.1269. View

Hong Z, Shi M, Chung K, Quinn J, Peskind E, Galasko D . DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain. 2010; 133(Pt 3):713-26. PMC: 2842513. DOI: 10.1093/brain/awq008. View

Bagheri H, Damase-Michel C, Lapeyre-Mestre M, Cismondo S, OCONNELL D, Senard J . A study of salivary secretion in Parkinson's disease. Clin Neuropharmacol. 1999; 22(4):213-5. View

Fujishiro H, Frigerio R, Burnett M, Klos K, Josephs K, DelleDonne A . Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord. 2008; 23(8):1085-92. DOI: 10.1002/mds.21989. View

Lang A, Lozano A . Parkinson's disease. First of two parts. N Engl J Med. 1998; 339(15):1044-53. DOI: 10.1056/NEJM199810083391506. View

Aguirre A, Banderas J, Haraszthy G, Reddy M, LeVine M . Sialochemistry: a diagnostic tool?. Crit Rev Oral Biol Med. 1993; 4(3-4):343-50. DOI: 10.1177/10454411930040031201. View

Lee H, Patel S, Lee S . Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci. 2005; 25(25):6016-24. PMC: 6724798. DOI: 10.1523/JNEUROSCI.0692-05.2005. View

Tumilasci O, Cersosimo M, Belforte J, Micheli F, Benarroch E, Pazo J . Quantitative study of salivary secretion in Parkinson's disease. Mov Disord. 2006; 21(5):660-7. DOI: 10.1002/mds.20784. View

10.

Beach T, Adler C, Sue L, Vedders L, Lue L, White Iii C . Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010; 119(6):689-702. PMC: 2866090. DOI: 10.1007/s00401-010-0664-3. View

11.

Rajput A, ROZDILSKY B . Dysautonomia in Parkinsonism: a clinicopathological study. J Neurol Neurosurg Psychiatry. 1976; 39(11):1092-100. PMC: 1083309. DOI: 10.1136/jnnp.39.11.1092. View

12.

Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K . Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol. 2007; 17(1):24-30. PMC: 8095543. DOI: 10.1111/j.1750-3639.2006.00032.x. View

13.

Johnston B, Li Q, Castell J, Castell D . Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol. 1995; 90(10):1741-6. View

14.

Silvers A, Som P . Salivary glands. Radiol Clin North Am. 1998; 36(5):941-66, vi. DOI: 10.1016/s0033-8389(05)70070-1. View

15.

Miki Y, Mori F, Wakabayashi K, Kuroda N, Orimo S . Incidental Lewy body disease restricted to the heart and stellate ganglia. Mov Disord. 2009; 24(15):2299-301. DOI: 10.1002/mds.22775. View

16.

Edwards L, Quigley E, Pfeiffer R . Gastrointestinal dysfunction in Parkinson's disease: frequency and pathophysiology. Neurology. 1992; 42(4):726-32. DOI: 10.1212/wnl.42.4.726. View

17.

Bloch A, Probst A, Bissig H, Adams H, Tolnay M . Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol. 2006; 32(3):284-95. DOI: 10.1111/j.1365-2990.2006.00727.x. View

18.

Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M . Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in lewy body disease. J Neuropathol Exp Neurol. 2007; 66(5):354-62. DOI: 10.1097/nen.0b013e3180517454. View

19.

Shi M, Zabetian C, Hancock A, Ginghina C, Hong Z, Yearout D . Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease. Neurosci Lett. 2010; 480(1):78-82. PMC: 2943649. DOI: 10.1016/j.neulet.2010.06.009. View

20.

Del Tredici K, Hawkes C, Ghebremedhin E, Braak H . Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol. 2010; 119(6):703-13. DOI: 10.1007/s00401-010-0665-2. View